 | • レポートコード：C-MOR-100214 • 出版社/出版日：Mordor Intelligence / 2019年9月 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Multi User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site License | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、軟組織同種移植の世界市場について調査・分析し、軟組織同種移植の世界市場規模、市場動向、市場環境分析、市場展望、セグメント別分析、地域別分析、関連企業情報など以下の構成でお届け致します。 |
Market Overview
Rising demand for Soft Tissue Allografts in athletics & other sports is contributing largely to the market growth. Modern training regimens in athletics, field events and a number of other contact sports like the American football, require athletes to undergo intensive training sessions which are in practice more strenuous than the actual sport itself.
High-intensity training regimens are directly correlated with athletic performance improvement but excessive training also induces muscle and bone fatigue and often leads to injury. Consequently, injury prevalence among athletes has been increasing especially due to excessive training. The competitive nature of sports has spurred the demand among athletes for quick recovery and easily accessible modalities to treat musculoskeletal injuries.
As a result, the demand for soft tissue allografts has been increasing in athletics and other contact sports, which in turn is fuelling the growth of the global soft tissue allografts market. Other factors contributing to the growth of this market include the scientific advancements in soft tissue repair and replacement and an increasing geriatric population.
Scope of the Report
Soft tissue allografts are the substitute tissues, having application in the reconstruction of deficient ligaments, spinal surgeries, torn menisci, and osteochondral defects during knee surgeries.
Key Market Trends
Dentistry is Expected to Witness a Healthy Growth Over the Forecast Period
In countries such as India, Australia, the United States, etc., more attention is given to the aesthetics and this results in rising aesthetic procedures. Dentistry is the sector which is currently witnessing a large number of aesthetic procedures to improve dental appearance.
Along with that, dental disorders such as Periodontitis are also on the rise. For instance, the National Institute of Health has stated that periodontitis is affecting around 20-50% of the global population. Also, NIH has stated that around 44% of the people aged 65 and more are prone to have periodontal disease. Therefore, the need for proper treatment has increased.
The soft tissue allografts are used to stop the gum recession and to improve the appearance of the same. Along with the improved gum aesthetics, soft tissues are also beneficial in curing the periodontal disease which is augmenting the demand for the same across the globe. hence, it is indicated that the dentistry segment will show satisfactory growth over the forecast period.
North America Dominates the Market
The global soft tissue allografts market has been segmented into five major regions, viz. North America, Europe, Asia Pacific, Middle East & Africa, and South America.
Driven by the United States, North America is expected to dominate the market in the coming future. This is majorly due to factors such as increasing prevalence of diabetic foot ulcers, better healthcare awareness program for diabetes and an increase in a number of surgical procedures on anterior cruciate ligament (ACL). Furthermore, technological development in dental implants and increasing expenditure by major & small key players for the development of soft tissue allografts are also boosting the growth of the market studied in the North America region.
Competitive Landscape
The soft tissue allografts market is moderately competitive and many of the global players are into the market. For instance, Allergan Plc., B. Braun Melsungen AG, Conmed Corporation, etc. are providing these products across the globe. Also, new product launches from these players are augmenting the demand for these products.
Reasons to Purchase this report:
The market estimate (ME) sheet in Excel format
Report customization as per the client’s requirements
3 months of analyst support
Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Geriatric Population
4.2.2 Increasing Demand for Soft Tissue Allografts in Athletics and Other Sports
4.2.3 Advancements in Soft Tissue Replacement
4.3 Market Restraints
4.3.1 High Cost of Treatment
4.3.2 Complicated Reimbursement Policies
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Cartilage Allograft
5.1.2 Tendon Allograft
5.1.3 Meniscus Allograft
5.1.4 Dental Allograft
5.1.5 Others
5.2 By Application
5.2.1 Orthopedic
5.2.2 Dentistry
5.2.3 Wound Care
5.2.4 Others
5.3 By End-User
5.3.1 Hospitals
5.3.2 Aesthetic Centres
5.3.3 Orthopedic Clinics
5.3.4 Dental Clinics
5.3.5 Others
5.4 Geography
5.4.1 North America
5.4.1.1 US
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Allergan Plc
6.1.2 B. Braun Melsungen AG
6.1.3 Conmed Corporation
6.1.4 Xtant Medical Holdings, Inc.
6.1.5 Alliqua BioMedical, Inc.
6.1.6 AlonSource Group
6.1.7 Becton Dickinson and Company
6.1.8 Arthrex, Inc.
6.1.9 Bone Bank Allografts
6.1.10 Osiris Therapeutics, Inc.
6.1.11 Integra LifeSciences Corporation
6.1.12 Stryker Corporation
7 MARKET OPPORTUNITIES AND FUTURE TRENDS